The Economic Engine — Why Generics Cost 80–85% Less
Generic pharmaceuticals are significantly more affordable because their manufacturers do not have to repeat the costly clinical trials (Phase I, II, and III) that the original developer performed. Instead, they submit an Abbreviated New Drug Application (ANDA).
The cost savings in 2026 are driven by three main factors:
No Research & Development Recoupment: Generic companies do not need to recover the billions of dollars spent on initial drug discovery.
Minimal Marketing: Unlike brand-name "blockbuster" drugs, generic versions are rarely advertised directly to consumers.
Market Competition: Once a patent expires, multiple generic companies often launch products simultaneously. This "multi-source" competition drives prices down to near-commodity levels, making life-saving treatments for chronic conditions like diabetes and hypertension accessible to millions.